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Abstract
Addition of β-lactam antibiotics to growing cultures of bacteria inhibit synthesis of the bacte-
rial cell wall peptidoglycan accompanied by killing (loss of viable titer) and lysis (physical dis-
integration) of the cells. However, it has also been well established that these antibiotics are
not effective in killing non-growing or slow-growing bacteria and the mechanism of this “anti-
biotic tolerance” is not well understood. In this study, we report on the genetic basis and phe-
notypic properties of an antibiotic tolerant derivative of the methicillin susceptible S. aureus
strain 27s. Cultures were exposed to “pulses” of high concentrations of oxacillin followed by
outgrowth of the surviving bacteria. This procedure quickly selected for antibiotic tolerant
mutants with an increased ability to survive antibiotic treatment without increase in the MIC
value for the antibiotic. Such mutants also exhibited longer lag phase, decreased lysis, virtu-
ally no change in antibiotic susceptibilities, cross tolerance to D-cycloserine and vancomy-
cin, and increase in biofilm formation in the presence of high concentrations of oxacillin.
Whole genome sequencing showed that these altered properties were linked to mutations in
the atl and gdpP genes.
Introduction
Staphylococcus aureus is a major pathogen and methicillin resistant strains of S. aureus
(MRSA) are often the primary cause of infections in hospital and clinical settings [1]. Antibiot-
ics such as beta lactams have been developed to treat such infections. In S. aureus resistance to
beta lactams such as methicillin or oxacillin arose through the acquisition of a foreign piece of
DNA called the SCCmec cassette, which carries the methicillin resistance determinant mecA
encoding the penicillin binding protein (PBP)2A –a key component of the resistance mecha-
nism in most MRSA isolates [2]. Generally, MRSA infections are dangerous and are the main
focus of concern. However, methicillin susceptible S. aureus (MSSA) are also pathogenic and
can acquire tolerance to β-lactams, i.e., the capacity to survive treatment with antibiotics. In
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antibiotic tolerance, susceptibility (i.e, MIC value) does not change but the bacteria are able to
survive the killing action of the antibiotic [3].
In an investigation by Griffith and O’Neill [4], S. aureus SH1000 was used as the parental
strain for isolating a mutant that was tolerant to both oxacillin and vancomycin and was found
to have a mutation in the gdpP gene [4]. Strain SH1000, a sub-lineage of strain 8325–4 [5, 6],
contains a 63 bp deletion in the spa-sarS intergenic region that was demonstrated to greatly
affect protein A transcription and sarS mRNA levels [7]. Protein A is a 42 kDa immunoglobu-
lin binding protein found in the cell wall of S. aureus and was shown to promote bacterial
aggregation and the formation of biofilms [8]. Strains of the 8325–4 lineage are also missing
phenol soluble modulin α3 (PSMα3), a virulence determinant linked to neutrophil chemo-
taxis, biofilm formation and surface spreading [5]. SH1000 is not considered a representative
model for in vivo studies because it does not carry protein A unlike most clinical isolates.
In the study described here, a derivative of strain NCTC8325 named strain 27s which con-
tains an intact spa-sarS intergenic region was used to obtain an oxacillin tolerant mutant.
Materials and methods
Strains and culture conditions
S. aureus parental strain 27s (also referred to as RN27) was provided by R. Novick, Public
Health Research Institute, New York, NY. Strain 27s/RN27 (ST8, spa type t211) is lysogenic
for phages F13 and 80α and was derived from S. aureus, strain RN25. In turn, strain RN25 was
derived by UV treatment from strain NCTC8325 (RN1) [9]. S. aureus tolerant mutants were
obtained from strain 27s by the protocol described below. S. aureus ATCC25923 and Staphylo-
coccus epidermidis strain ATCC12228 were used as controls in some of the assays. S. aureus
strain 27sAtl contains a mutated atl gene obtained by transduction with phage 80α from the
autolysis-deficient mutant RUSAL2 [10].
All strains were stored at -70˚C in tryptic soy broth (TSB; Difco Laboratories, Detroit,
Mich.) containing 10% glycerol. Overnight cultures were grown by inoculating 50 μl of the
bacterial stocks into 5 ml of tryptic soy broth and incubating at 37˚C in glass tubes with aera-
tion overnight. All experiments were done with exponentially growing cultures in mid-log
phase obtained by inoculating 0.2 ml of the overnight culture into fresh pre-warmed TSB (50
ml) and cultivation at 37˚C under aerobic conditions. Bacterial growth was monitored by mea-
surement of the OD at 620 nm (OD620) with a spectrophotometer (Pharmacia LKB Novaspec
II, Piscataway, NJ, USA).
Selection of mutants tolerant to oxacillin
A mutant tolerant to oxacillin was obtained by cyclic exposure of strain 27s to “pulses” of high
concentration of oxacillin (15X MIC). First, 50 μl of an overnight culture of 27s grown in TSB
was inoculated into 50 ml of fresh pre-warmed TSB. Oxacillin at 15 X MIC (1.5 mg/L) was
added to the culture when the OD620 nm reached 0.2–0.4. Measurements of the OD620 were
taken every hour and aliquots of 1 ml were removed at 0, 3, 5 and 24 hours to assay bacterial
survival (Figs 1 and 2A–2C).
From the aliquot taken at 5 hours, 100 μl of the washed, antibiotic free suspension was inoc-
ulated into 5 ml of TSB and incubated overnight with aeration at 37˚C. The overnight culture
was diluted the next morning in fresh TSB and oxacillin at 15 X MIC (1.5 mg/L) was added
when the culture reached mid-log phase. Every time this process was repeated it will be
referred to as a “cycle”. A mutant “tolerant” to oxacillin was obtained after 14 cycles of treat-
ment with the antibiotic (mutant 14c).
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Growth curves
Overnight cultures of strain 27s and the tolerant mutant were diluted into fresh prewarmed
TSB and absorbance at OD620 nm was measured every 60 minutes. The measurements were
plotted and the doubling times were calculated from the graph. Growth rates were calculated
by the formula k = log(Xt)–log(X0) / 0.301t (see Fig 1).
Antibiotic-induced lysis
To assess antibiotic-induced lysis, antibiotics (oxacillin, vancomycin or D-cycloserine) were
added at concentrations of 15 times the MIC when the culture (at 37˚C) reached an
Fig 1. Growth curves of S. aureus parental strain 27s, tolerant mutants 14c, 14c5p and 27sAtl. Bacterial cultures were
grown in TSB at 37˚C with aeration.
https://doi.org/10.1371/journal.pone.0199707.g001
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absorbance of about 0.2 to 0.4 (corresponding to 107 to 108 log10 CFU/ml). The absorbance at
OD620 nm was measured every 60 minutes for five hours after the addition of antibiotic and
also after 24 hours (Fig 2A–2C).
Viability of strains after addition of antibiotic
To determine the number of survivors of a strain after treatment with 15X MIC of the antibi-
otic, aliquots of 1 ml were removed at 0, 3, 5 and 24 hours. The 1 ml aliquots were centrifuged
in eppendorf tubes for 5 minutes at 13,000 rpm. The supernatant was discarded and the pellet
was suspended with 1 ml of TSB. The pellet was washed 3X with 1ml of TSB to remove the
antibiotic, suspended with 1 ml of TSB and diluted to -1, -2,-3,-4, -5 and -6 with TSB. 100 μl
from each dilution were plated on TSA plates and incubated at 37˚C overnight. The CFU were
counted and the number of survivors determined for each strain as the log CFU reduction
between the control and the 3, 5, and 24 h culture in the presence of antibiotic (Fig 2). Log
reductions were calculated according to http://microchemlab.com/log_reduction_and_
percent_reduction_calculations.
Fig 2. Growth of strain 27s and mutants 14c, 14c5p and 27sAtl in the presence of antibiotics. Antibiotics were added at the time indicated () to the cultures (100 ml)
of the exponential phase bacteria (OD620 = 0.2–0.4 nm). The antibiotics tested and the concentrations used were: (A) oxacillin (15 X MIC, 1.5 mg/L), (B) D-cycloserine
(15 X MIC, 22 mg/L) and (C) vancomycin (15 X MIC, 15 mg/L). The top panel follows the lysis of the cultures by reading the OD620 after the addition of the antibiotic
at time 0 and every hour for 5 hours and then after 24 hours. The bottom panel shows the effect of antibiotics (A) oxacillin, (B) D-cycloserine and (C) vancomycin at the
concentration of 15 X MIC on the viability of the wild type 27s and mutant strains. Viability was determined by serial dilutions of aliquots taken at 0, 3, 5 and 24 hours
onto tryptic soy agar plates and counting the CFU’s after 24 hour incubation of the plates at 37˚C.
https://doi.org/10.1371/journal.pone.0199707.g002
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Testing for stability of 14th cycled oxacillin mutant (mutant 14c)
The 14th cycled oxacillin tolerant mutant was streaked on a TSA plate and incubated at 37˚C
overnight. A single colony was inoculated into 5 ml antibiotic free TSB and incubated at 37˚C
with rotation for 18 hours. After 18 hours, 10 μl of the overnight culture was diluted into fresh
pre warmed TSB. This process was repeated 4 more times for a total of five passages of the 14th
cycled oxacillin mutant (14c5p)
Fig 3. Population analysis profiles and Etest of parental strain 27s, and mutants. Stationary phase cultures of 27s, 14c, 14c5p and 27sAtl were plated with several
dilutions on agar plates containing increasing concentrations of (A) oxacillin or (B) d-cycloserine (C) Vancomycin susceptibility of 27s, 14c5p and 27sAtl were
determined by Etest.
https://doi.org/10.1371/journal.pone.0199707.g003
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Antibiotic susceptibility
All strains were tested for antimicrobial susceptibility by disk diffusion, Etest and Population
Analysis Profiles.
The standard disc diffusion test on Tryptic Soy Agar was performed as follows: overnight
cultures were inoculated into TSB and incubated at 37˚C until they reached an OD620 equal
to a MacFarland 0.5 standard. Bacterial cultures were then plated onto TSA and antibiotic
disks (BD, BBL, Franklin Lakes, NJ) were placed on the plates. The plates were incubated at
37˚C for 18–24 hours. The diameters (in millimeters) of clear zones were measured. The anti-
biotic sensi disc (BD, BBL, Sensi-Disc, Becton Dickinson and Company, USA), with the con-
centrations that were tested included: penicillin G (10 μg), ciprofloxacin (5 μg), erythromycin
(15 μg), gentamicin (10 μg), linezolid (30 μg), nitrofurantoin (300 μg), rifampin (5 μg), and tet-
racycline (30 μg). Each strain was classified either as Resistant(R), Intermediate (I) or Suscepti-
ble (S)–according to guidelines developed by the Clinical and Laboratory Standards Institute
recommendations [11].
The Etest was performed by spreading a small aliquot of overnight culture diluted to an
OD620 of 0.08 onto TSA plates and adding an Etest strip of oxacillin, vancomycin, daptomy-
cin, cefoxitin or daptomycin onto the surface of the plate. MIC values of the antibiotic were
determined after 24 hour incubation at 37˚C (Fig 3).
PAPs were done on overnight cultures diluted with TSB and plated on TSA plates contain-
ing serial (2 fold) dilutions of oxacillin, vancomycin or D-cycloserine according to the popula-
tion analysis method as previously described [12] (Fig 3).
Biofilm formation
The biofilm assay was done by an adaptation of a protocol using crystal violet [13, 14]. Parental
wild type S. aureus strain 27s, tolerant mutants 14c and 14c5p and control strains ATCC25923
and ATCC12228 were inoculated into 5 ml of TSB and incubated at 37˚C with aeration over-
night. The overnight cultures (50 μl) were diluted into 50 ml of pre-warmed TSB with 2% (w/
v) glucose to maximize ica operon induction, as reported [15] and incubated at 37˚C with agi-
tation until the culture reached an OD620 = 0.5–0.7. Aliquots (4 ml) of each culture were added
to 6 well plates and incubated at 37˚C for 24 hours (Fig 4A). After incubation, 3.8 ml of the cul-
ture fluids from each well were carefully aspirated, the plate inverted and blotted on paper tow-
els 3X. In order to remove the unattached cells and media components, 4 ml of sterile distilled
water was added into each well. The water wash was aspirated and the plate blotted on paper
towels 3X and was repeated twice. Crystal violet solution (4 ml of 0.1%) was added to each well
and the plates were incubated at room temperature for 15 minutes. The crystal violet solution
was removed by aspiration and the wells were rinsed 3 X with 4 ml sterile distilled water. The
plate was blotted 3 X on paper towels. The plate was then incubated at 80˚C for 1 hour to fix
the stain. Next 4 ml of 10% SDS in 40% ethanol was added to each well. The plate was left at
room temperature for 30 minutes. 1 ml of the solubilized crystal violet from each well was
transferred to a Sarstedt cuvette and the absorbance at OD600 nm was measured using a spec-
trophotometer (Fig 4B).
Biofilm formation in glass test tubes
Strains 27s, the tolerant mutants 14c and 14c5p, strain 27sAtl and controls ATCC25923 and
ATCC12228 were streaked on TSA plates. The plates were incubated at 37˚C overnight for 18
hours. A single colony from each strain was inoculated into glass test tubes containing 6 ml
TSB with 2% (w/v) glucose and incubated with rotation at 37˚C for 18 hours (Fig 4C).
Properties of an oxacillin tolerant laboratory mutant of Staphylococcus aureus
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Whole-genome sequencing
Genomic DNA was extracted from the parental strain 27s and from the oxacillin tolerant
mutant 14c5p using the Qiagen DNeasy Blood & Tissue Kit (QIAGEN, Ambion Inc., Austin,
TX, USA). Paired-ended (2 x 250 bp) sequencing was performed at the Instituto Gulbenkian
de Ciência (IGC, Oeiras, Portugal) using the Illumina MiSeq platform. Quality control of
reads, de novo assembly and contigs quality assessment, and possible contamination search
was carried out using the multi-software pipeline INNUca version 2.6 (https://github.com/
B-UMMI/INNUca). Selected assemblies for parental isolates were inspected and subsequently
annotated using Prokka (https://github.com/tseemann/prokka) (version 1.12). Mean depth of
coverage (post quality control) ranged from 98- and 88-fold for 27s and 14c5p, respectively.
Quality processed reads of 14c5p were mapped against the corrected assembly of the parental
strain using Snippy v3.1 (https://github.com/tseemann/snippy) with the following criteria: i)
minimum mapping quality of20; ii) minimum number of 10 quality processed reads cover-
ing the variant position; iii) a minimum proportion of 90% of quality processed reads at the
variant position differing from the reference. All mutations were inspected and confirmed
using Integrative Genomics Viewer (http://software.broadinstitute.org/software/igv/).
Fig 4. Comparison of biofilm formation between 27s, tolerant mutants and control strains. (A) in plastic 96-well plates measured by the crystal violet assay; (B)
Spectrophotometric values at OD600nm quantifying the recovery of crystal violet from stained biofilms; (C) Biofilm formation in TSB medium with 200/0 glucose after
24 hours incubation at 37˚C with rotation.
https://doi.org/10.1371/journal.pone.0199707.g004
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Read sequences for the isolates used in this study
The sequences for the S. aureus isolates are in the Sequence Read Archive (SRA) under the Bio-
project (http://www.ebi.ac.uk/ena/data/view/ERS2296040 and http://www.ebi.ac.uk/ena/data/
view/ERS2296041) and can be downloaded from the NCBI’s website (http://www.ncbi.nlm.
nih.gov/).
Results
In a search for the genetic basis and phenotypes of βlactam tolerance, we isolated a tolerant
mutant, designated as 14c5p [i.e., obtained after five passages of a 14th cycled oxacillin mutant
(14c)], from the parental strain 27s, which is a derivative of the MSSA strain NCTC8325. Com-
parison at the whole-genome level revealed only two mutations in the tolerant strain: one inacti-
vating mutation in the atl gene, which encodes a bifunctional autolysin [16] and a missense
mutation in the gdpP gene, which encodes the cyclic-di-AMP phosphodiesterase GdpP (Table 1).
Whereas GdpP is already known to mediate tolerance to βlactams and glycopeptides [4], no
direct link has been established as yet for atl. We thus generated an atl truncated mutant (27sAtl)
to investigate potential changes in phenotypic properties.
No change in antibiotic susceptibilities
The tolerant mutants 14c and 14c5p remained susceptible to all eight antibiotics tested by disk
diffusion and Etest (results not shown). The population analysis profiles (PAPs) of the tolerant
mutant for oxacillin, vancomycin and D-cycloserine were virtually identical to that of the
parental strain 27s (Fig 3).
Prolonged lag phase before exponential phase
A unique property of the tolerant laboratory isolate was the prolonged lag (186 min) before
resumption of exponential growth when stationary phase overnight cultures were diluted into
fresh medium (Fig 1). The doubling time of tolerant mutants 14c and 14c5p was 32 minutes
about the same as that of 27s (31 minutes) in the exponential growth phase. The 27s Atl mutant
showed a similar lag time of 186 minutes and doubling time of 32 minutes (Fig 1).
Oxacillin induced lysis of the tolerant mutant 14c5p was much slower than that of the paren-
tal strain 27s (Fig 2A). When 15 x MIC (1.5 mg/L) oxacillin was added to mid log cultures of the
parental strain 27s and the tolerant mutant at the OD620 = 0.3, the 27s culture grew only to an
OD620 of 0.539, while the tolerant mutant was able to grow up to OD620 = 0.798. The optical
density OD620 nm of the 27s culture started to decrease at OD620 = 0.53, i.e., 3 hours after the
addition of oxacillin to the medium, while the tolerant mutant showed no decrease in optical
density (at OD620 = 0.798) during the same time period. After overnight incubation of the cul-
tures with oxacillin, the parental strain 27s showed almost complete lysis while the optical den-
sity of the tolerant mutant did not decline.
Table 1. Mutations found in the tolerant mutant 14c5p.
Mutation Effect Nucleotide Amino Acid Gene Locus tag Product
number change change in reference
1 stop_gained 2194C>T Gln732 atl SAUSA300_0955 Bifunctional autolysin
2 missense_variant 1301C>A Ala434Glu gdpP SAUSA300_0014 Cyclic-d-AMP phosphodiesterase GdpP
According to the genome annotation of the reference strain USA300_FPR3757 (accession number CP000255) [17]
https://doi.org/10.1371/journal.pone.0199707.t001
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There was only a 2 log reduction in survivors for the tolerant mutant culture after 3 hours
of exposure to 15X MIC oxacillin as compared to a 6 log reduction in the number of survivors
of the parental culture (Fig 2A). After 24 hours exposure to high concentrations of oxacillin,
the tolerant mutant had a 5 log reduction in viability, while the parental culture had a 7 log
reduction in viability.
The phenotypes of longer lag phase, decreased lysis and increase in the number of survivors
in the exponential phase was stable in the oxacillin tolerant mutant after five passages in antibi-
otic free TSB (14c5p) (Fig 2).
Increase in biofilm production
S. aureus exposed to low concentrations of beta lactam antibiotics such as oxacillin can induce
the formation of biofilm [17]. Biofilm assays showed that the 14c mutant and its 14c5p deriva-
tive produced 2.5 times the amount of biofilm as compared to the 27s parental strain. A huge
ring of biofilm was observed inside the surface of the glass test tube when 14c and 14c5p were
grown in TSB (Fig 4C). Aggregate formation was also observed at the bottom of the flasks for
14c and 14c5p, but not in strains 27s and 27sAtl (not shown).
Cross tolerance to other antibiotics
The 14th cycled mutant displayed cross-tolerance to the glycopeptide antibiotic vancomycin.
The vancomycin MICs of strains 27s and the oxacillin tolerant mutant 14c5p were both 1 mg/
L by Etest. The oxacillin tolerant mutant exhibited a reduction in killing compared with 27s
after 3 and 5 hours exposure to 15 X MIC (15 mg/L) of vancomycin. There was a two-log
reduction in survivors in the 27s culture as compared to one log reduction for the 14c5p
mutant after 3 hours exposure, while there was a three log reduction for strain 27s and a one
log reduction for the 14c5p mutant after 5 hours (see Fig 2).
Mutant 14c5p also showed tolerance to D-cycloserine. The D-cycloserine MIC of strain 27s
and the mutant were 25 mg/L each. There were more survivors in the mutant during the expo-
nential growth period than in 27s when treated with 15X MIC of D-cycloserine (22 gm/L).
There was a three log reduction for the 27s and a one log reduction for the mutant 14c5p after
3 and 5 hours treatment with the antibiotic (see Fig 2).
The 27sAtl mutant also showed tolerance to both oxacillin and D-cycloserine, and slight
tolerance to vancomycin. The oxacillin MICs of strains 27sAtl and 27s were both 0.125 mg/L
by Etest. The D-cyloserine MIC for 27sAtl and 27s were both 25 mg/L by PAP. The lag period
of 27sAtl mutant (186 minutes) was longer than the lag phase of the 27s strain (138 minutes)
(Fig 1). There was a three-log reduction in the number of survivors after 3 hours treatment of
27sAtl with 15X MIC oxacillin and a six log reduction in the number of survivors for 27s.
There was a four-log reduction for 27sAtl and a six-log reduction for 27s after 5 hours expo-
sure to 15 X MIC oxacillin. There was a two-log reduction in the number of survivors when
27sAtl was treated with 15X MIC D-cycloserine (375 mg/L) compared to three-log reduction
for 27s after 3 hours. After 5 hours, there was still a two-log reduction for 27sAtl and a three-
log reduction for 27s treated with 15X MIC D-cycloserine. There was a slight tolerance to van-
comycin when 27sAtl was treated with 15X MIC vancomycin (22.5 mg/L) as compared to 27s
and less tolerance than in mutant 14c5p (see Fig 2).
Discussion
Whole genome sequencing of the oxacillin tolerant mutant described in this study identified
mutations in two genes when compared to the non-tolerant parental strain: one loss-of-func-
tion mutation in the atl gene and a non-synonymous mutation in gdpP. An earlier study by
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Griffith et al used SH1000 as the parental strain and identified only a loss-of-function mutation
in the gdpP gene [4]. This reinforces the role of the latter in antibiotic tolerance and points to
atl as a putative novel mediator of this phenotype.
Atl, is a 137.5 kDa bifunctional protein with two domains: AM (amidase) and GL (glucosa-
minidase) that are processed outside the cell and adhere to the staphylococcal surface at spe-
cific locations of the equatorial surface rings. [16, 18]. Analysis of the lysis products of S.
aureus peptidoglycan indicates that the enzyme may be classified as an N-acetylmuramyl-l-ala-
nine amidase [19]. Atl is involved in the separation of daughter cells during cell division and it
also contributes to cell wall turnover and antibiotic-induced lysis [20], which are mechanisms
that may support the phenotypes observed in our study, namely that the inactivation of the atl
gene in parental strains has led to extended lag phase and cross tolerance to several antibiotics.
One virulence property of S. aureus is the capacity to form biofilm which involves two pro-
cesses: attachment to a surface and cell clustering abetted by a slimy material called the poly-
saccharide intercellular adhesin, PIA [21]. Atl deletion mutants were shown to have decreased
biofilm formation [19]. Intriguingly, in our study, the 14c5p mutant produced 2.5 x more bio-
film than the parental strain 27s, and yet the 27sAtl mutant had the same amount of biofilm as
the parental strain–as determined by the crystal violet stain assay. The lack of impact of the
deletion of atl on the biofilm phenotype has been shown previously [22]. Mutant 27sAtl did
not form aggregates nor showed the stickiness to the surfaces of glass tubes–in contrast to
strain 14c5p grown in TSB. As such, the biofilm-associated phenotype observed for 14c5p is
likely provided by the non-synonymous mutation in gdpP.
GdpP (GGDEF domain protein containing phosphodiesterase) is a phosdiesterase that
degrades c-di-GMP and c-di-AMP in bacteria such as S. aureus. Cyclic diadenosine mono-
phosphate (c-di-AMP) is synthesized from two molecules of ATP by the diadenylate cyclase
enzyme, DacA and is degraded into pApA by GdpP [23, 24]. C-di-AMP is a signaling molecule
and is a second messenger in S. aureus. It has been shown that deletion of gdpP in S. aureus
increases intracellular levels of c-di-AMP and decreases the size of the bacterial cell. C-di-
AMP, stimulates the biosynthesis of adhesins and promotes biofilm formation. Strains with
deleted GdpP produce approximately 3X the amount of biofilm as compared to the WT strain
[24]. In our study, the 14th cycled oxacillin mutant produced 2.5 X the amount of biofilm as
compared to the parental strain 27s. Considering that this mutant carries a non-synonymous
mutation in gdpP (while mutants in other studies had gdpP deleted), one may speculate that
non-inactivating mutations may be sufficient to reduce the phosdiesterase activity, yielding a
cascade of phenotypes: accumulation of C-di-AMP, promotion of biofilm formation and, ulti-
mately, antibiotic tolerance. Indeed, an increase of biofilm formation can slow the penetration
of β-lactams and aminoglycosides in bacteria giving the bacteria a longer survival period [25]
The oxacillin tolerant mutants 14c and 14c5p described in this communication and strain
27sAtl each showed cross tolerance to D-cyloserine and vancomycin. In the study by Griffith
et al, deletion of GdpP in SH1000 oxacillin tolerant mutant also showed cross tolerance to van-
comycin [4]. D-cycloserine is a cyclic analog of D-alanine that blocks the early cytoplasmic
phase of peptidoglycan synthesis by inhibiting D-alanyl-D-alanyl ligase (Ddl). On the other
hand, vancomycin is a glycopeptide antibiotic which inhibits cell wall synthesis by binding the
D-ala-D-ala of the lipid II and sterically hindering transglycosylation and transpeptidation.
Similarly to oxacillin, vancomycin blocks the late stage of peptidoglycan biosynthesis by inhib-
iting the action of PBPs that cross-link the immature peptidoglycan [26]. In this context, our
observation that cross tolerance can involve antibiotics targeting both the early (D-cycloserine)
and late stages (vancomycin and oxacillin) of peptidoglycan synthesis further supports that the
gdpP/atl-mediated mechanisms of tolerance are beyond the specific molecular pathways where
antibiotics are known to act. Considering that 27sAtl mutant displayed both vancomycin and
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D-cycloserine tolerance, but these phenotypes were less marked than the ones observed for the
14c5p strain (double mutant), it is reasonable to hypothesize that the enhanced phenotype in
14c5p relies on the synergistic effect of atl and gdpP mutations.
In summary, an oxacillin tolerant S. aureus laboratory mutant described here has several
unique properties including longer lag phase; decreased lysis; increase in the amount of survi-
vors in the exponential phase; virtually no change in antibiotic susceptibilities, cross tolerance
to D-cycloserine and vancomycin and increase in biofilm formation in the presence of high
concentrations of oxacillin. These phenotypes can be linked to gdpP gene, through either its
deletion (previous studies) or discrete mutations (our study), and to the inactivation of atl
gene, a potential novel mediator of S. aureus ability to acquire antibiotic tolerance during the
course of treatment.
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